Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Global Artemisinin Market Report 2024, Featuring Profiles of Top Players Including Sanofi, Artemis, KPC Pharmaceuticals, Guilin Pharmaceutical, KERUI, Phytomedics, AIFLINC, Alchem and Sanmark

      Research and Markets Logo

      News provided by

      Research and Markets

      Mar 07, 2024, 23:30 ET

      Share this article

      Share this article


      DUBLIN, March 7, 2024 /PRNewswire/ -- The "Global Artemisinin Market by Type By Application, by Distribution Channel, and By Region" report has been added to  ResearchAndMarkets.com's offering.

      The global artemisinin market size was estimated to be USD 96.1 million in 2023 and is expected to reach USD 677.9 million by 2034 with a CAGR of 19.43% during the forecast period 2024-2034. The rising burden of malaria, increased access to artemisinin-based combination therapies, growing awareness of the benefits of artemisinin, research, and development into new artemisinin-based treatments, and government support for malaria control will drive the market growth.

      ACTs are the first-line treatment for malaria recommended by the WHO. They combine artemisinin with other antimalarial drugs, making it more difficult for the parasites to develop resistance. Access to ACTs has increased significantly in recent years, thanks to initiatives such as the Affordable Medicines Facility for Malaria (AMFm) and the President's Malaria Initiative (PMI). For instance, in November 2023, Artemis International Inc., in partnership with the Kenyan Agricultural Research and Livestock Organization, introduced a new, high-yielding cultivar of Artemisia Annua. obtained a grant of USD 5 million from USAID for projects about sustainable production.

      By type, the extraction from the artemisia annua segment accounted for the highest revenue-grossing segment in the global artemisinin market in 2023 owing to the primary source of artemisinin, with pharmaceutical companies relying on a consistent and high-quality supply to meet the increasing global need for effective and life-saving anti-malarial medications. Additionally, the semisynthetic artemisinin segment is predicted to grow at the fastest CAGR during the forecast period owing to the advancements in pharmaceutical research and development, which have led to the synthesis of semisynthetic artemisinin with enhanced properties and improved scalability.

      By application, the antimalarial tablets segment accounted for the highest revenue-grossing segment in the global artemisinin market in 2023 owing to the growing prevalence of malaria worldwide and the widespread adoption of artemisinin-based combination therapies (ACTs) encapsulated in antimalarial tablets. Additionally, the antimalarial injections segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing demand for rapid and potent treatment options, particularly in severe malaria cases, where the prompt administration of artemisinin-based therapies is critical.

      By distribution channel, the hospital pharmacy segment accounted for the highest revenue-grossing segment in the global Artemisinin market in 2023 owing to the increasing number of cochlear implant surgeries performed in hospital settings and the rising prevalence of hearing impairment globally. Additionally, the online pharmacy segment is predicted to grow at the fastest CAGR during the forecast period owing to the growing trend of digitalization in healthcare services, increased consumer preference for online shopping, and the convenience offered by online pharmacies in providing a wide range of pharmaceutical products, including cochlear implants.

      North American region is anticipated to have the highest revenue share during the forecast period owing to the presence of a well-established healthcare infrastructure, increasing prevalence of hearing disorders, high adoption of advanced medical technologies, and a robust reimbursement framework. Additionally, the Asia Pacific region is predicted to grow at the fastest CAGR during the forecast period owing to the rising awareness of hearing impairment, increasing healthcare investments, expanding patient population, and improving accessibility to advanced medical treatments. 

      Report Scope:

      • Base Year: 2023
      • Forecast Period: 2024-2034
      • Study Coverage
      • Market Forecast by Type, Application, and Distribution Channel
      • Market Forecast for 5 Regions and 17+ Countries
        • North America (U.S. and Canada)
        • Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
        • Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
        • Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
        • MEA (South Africa, GCC, Rest of MEA)
      • Company Profiles of the Top 10+ Major Market Players

      Key Topics Covered:

      1. Research Methodology

      2. Introduction
      2.1. Market Definition
      2.2. Global Artemisinin Market Overview

      3. Executive Summary

      4. Market Environment Analysis
      4.1. Porter's 5 Forces Analysis
      4.2. PESTEL Analysis
      4.3. SWOT Analysis

      5. Market Dynamics

      6. COVID-19 Impact Analysis

      7. Artemisinin Market: Type Estimates & Trend Analysis
      7.1. Type Segment Opportunity Analysis
      7.2. Extraction from Artemisia Annua
      7.3. Semisynthetic Artemisinin

      8. Artemisinin Market: Application Estimates & Trend Analysis
      8.1. Application Segment Opportunity Analysis
      8.2. Antimalarial Injections
      8.3. Antimalarial Tablets

      9. Artemisinin Market: Distribution Channel Estimates & Trend Analysis
      9.1. Distribution Channel Segment Opportunity Analysis
      9.2. Hospital Pharmacy
      9.3. Retail Pharmacy
      9.4. Online Pharmacy

      10. Regional Market Analysis
      10.1. Regional Market Opportunity Analysis

      11. North America Artemisinin Market

      12. Europe Global Artemisinin Market

      13. Asia Pacific Global Artemisinin Market

      14. Latin America Global Artemisinin Market

      15. MEA Global Artemisinin Market

      16. Competitor Analysis
      16.1. Company Market Share Analysis, 2023
      16.2. Major Recent Developments

      17. Company Profiles

      • Sanofi
      • Artemis International Inc.
      • KPC Pharmaceuticals Inc.
      • Guilin Pharmaceutical Co. Ltd.
      • Kunming Pharmaceutical Corporation
      • KERUI Group (Artemisinin Biotech)
      • Phytomedics Inc.
      • Natural Remedies Pvt. Ltd.
      • AIFLINC
      • Alchem International Pvt Ltd.
      • Sanmark Corp.


      For more information about this report visit https://www.researchandmarkets.com/r/avsljk

      About ResearchAndMarkets.com
      ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


      Media Contact:

      Research and Markets
      Laura Wood, Senior Manager
      [email protected]
       
      For E.S.T Office Hours Call +1-917-300-0470
      For U.S./CAN Toll Free Call +1-800-526-8630
      For GMT Office Hours Call +353-1-416-8900
       
      U.S. Fax: 646-607-1907
      Fax (outside U.S.): +353-1-481-1716

      Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

      SOURCE Research and Markets

      Modal title

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.